CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Guizhou Xinbang Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Guizhou Xinbang Pharmaceutical Co Ltd
No. 227
Xinbang Avenue
Phone: +86 85188660261p:+86 85188660261 GUIYANG, GUZ  550018  China Ticker: 002390002390
Business Summary
GUIZHOU XINBANG PHARMACEUTICAL Co., LTD is a China-based company, principally engaged in the research and development, manufacture and distribution of medical products. The Company operates its businesses through three segments. The Pharmaceutical Manufacturing segment is engaged in the manufacture and distribution of Chinese patent medicines, such as Ginkgo Leaves Tablets. The Pharmaceutical Distribution segment includes rapid wholesale business and medicine retail business. The Medical Services segment is engaged in the provision of medical services. It operates its businesses primarily in domestic markets.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
5122 Drugs, drug proprietaries, and druggists' sundries
0139 Field crops, except cash grains, not elsewhere classified
8062 General medical and surgical hospitals

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board JiAn 31 5/6/2022 5/6/2022
Chief Financial Officer, Deputy General Manager YayunXiao 51 5/12/2015 5/12/2015
General Manager, Director LingzhongKong 56 8/5/2016 3/1/2003
9 additional Officers and Directors records available in full report.

General Information
Number of Employees: 5,149 (As of 12/31/2023)
Outstanding Shares: 1,943,851,868 (As of 9/30/2024)
Shareholders: 73,079
Stock Exchange: SHE
Fax Number: +86 85188660280


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, November 22, 2024